About Hatchtech

Treatment of head lice infestation with a single, 10-minute application.


Hatchtech has an experienced board of directors with skill sets and backgrounds spanning science, finance, business development and drug development. The members of the Hatchtech board are as follows:

Latest News

Aug 03, 2020 Xeglyze FDA Approval

Sep 14, 2015 Commercialisation Deal and NDA Filed

Sep 02, 2014 Hatchtech Announces Successful Phase 3 Results

Oct 31, 2013 Hatchtech Completes $12.6m Capital Raise, Secures Funds for Phase III and NDA Submission